
The CKD Screening Prioritizer (CSP)
A tool that supports the identification of undiagnosed Chronic Kidney Disease (CKD) amongst adults with type 2 diabetes.
Potiential to change the disease course
No biochemical testing required
Created using inputs that are all either readily available or easily collected
Enables efficient screening resource allocation

Diabetes is the leading cause of kidney failure globally, it is reported that approximately 1 in 3 adults with diabetes may have chronic kidney disease.
Early-stage CKD is often asymptomatic, early detection offers the potential to slow the progression and improve patient outcomes. Making screeing vital.
But, in reality, CKD screening doesn’t take place as often as it’s supposed to…
There has been a 40% reduction in Serum Creatinine testing
Screening programs were disrupted during the Covid-19 pandemic
During the Covid-19 pandemic patient reviews were delayed and there was widespread disruption to screening programs, creating a need for a pre-screening solution.
The burden of diabetes is rising more rapidly in low- and middle-income countries
Lower to middle income countries face huge challenges
Screening every patient isn’t possible in lower to middle income countries due to the limited resources available combined with the increased risk of chronic kidney disease in patients with type 2 diabetes.
A minimal resource model

– Dr Camilla Sammut-Powell, Lead Data Scientist at Gendius
CSP, has successfully completed usability testing conducted by its intended user group, healthcare professionals, in line with ISO/IEC 62366 standards. The human factor testing guarantees that CSP is not only user-friendly but also highly effective in real-world healthcare scenarios. The completion of this usability test reaffirms that CSP is easy to use, intuitive, and tailored to meet the specific needs of healthcare professionals, ensuring seamless integration into their workflow. We are confident that our innovative solution will significantly enhance the efficiency of healthcare system and, ultimately, improve patient care.
Our scalable solutions
We have created two solutions for different use cases, both use the same application programming interface (API) to transfer information and algorithms to calculate the results.

Simple and personal
Single patient upload
Enter an individual’s inputs into the web-portal risk calculator.
Suitable for:
- Smaller clinics
- Clinics with limited resources
- Clinics looking to focus on individual patients

Efficient and scalable
Bulk patient upload
- Clinics with an existing Electronic Health Record System and an IT team available.

Innovation at scale
– Rory Cameron, CEO & Co-Founder at Gendius
– Susana Goncalves, CVRM Medical Director, AstraZeneca International.
CKD Screening Prioritizer (CSP) has successfully completed usability testing conducted in accordance with ISO/IEC 62366:2015 standards. The tests were rigorously carried out with healthcare professionals, ensuring that CSP not only meets but exceeds the usability and functionality requirements outlined in the international standard. We are confident that our innovative solution will greatly benefit healthcare professionals and enhance patient care.
Updates
Publications
Future Healthcare Journal
Development of minimal resource pre-screening tools for chronic kidney disease in people with type 2 diabetes
Camilla Sammut-Powell, Rose Sisk, Jayne Budd, Natasha Patel, Mark Edge and Rory Cameron
For more information